argenx SE | ARGX - Gross Profit On Sales

Stock Price
675.60
Daily Change
-17.60 -2.54%
Monthly
-4.52%
Yearly
33.25%
Q2 Forecast
678.23

argenx SE reported $1.18B in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
AstraZeneca USD 12.61B 225M Mar/2026
Genmab DKK 977M 13M Dec/2025
GlaxoSmithKline GBP 5.75B 429M Mar/2026
GRIFOLS EUR 686.84M 56.95M Dec/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Lakefront Biotherapeutics EUR 1.68M 898.68M Mar/2026
Qiagen NV USD 325.27M 19.53M Dec/2025
UCB EUR 3.19B 621M Dec/2025